| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Cormorant Asset Management, LP | $25.9M | 2.5M | ▲New +2.5M sh | Q1 2026 | |
| 2 | TCG Crossover Management, LLC | $21.5M | 2.1M | ▲New +2.1M sh | Q1 2026 | |
| 3 | FEDERATED HERMES, INC. | $17.0M | 1.6M | ▲New +1.6M sh | Q1 2026 | |
| 4 | Casdin Capital, LLC | $16.3M | 1.6M | ▲New +1.6M sh | Q1 2026 | |
| 5 | FMR LLC | $15.3M | 1.5M | ▲New +1.5M sh | Q1 2026 | |
| 6 | Nantahala Capital Management, LLC | $12.9M | 1.2M | ▲New +1.2M sh | Q1 2026 | |
| 7 | Aberdeen Group plc | $7.4M | 708K | ▲New +708K sh | Q1 2026 | |
| 8 | PERCEPTIVE ADVISORS LLC | $6.3M | 600K | ▲New +600K sh | Q1 2026 | |
| 9 | Samsara BioCapital, LLC | $6.3M | 600K | ▲New +600K sh | Q1 2026 | |
| 10 | Siren, L.L.C. | $4.3M | 411K | ▲New +411K sh | Q1 2026 | |
| 11 | LMR Partners LLP | $3.1M | 300K | ▲New +300K sh | Q1 2026 | |
| 12 | Redmile Group, LLC | $1.6M | 156K | ▲New +156K sh | Q1 2026 | |
| 13 | MILLENNIUM MANAGEMENT LLC | $999K | 95K | ▲New +95K sh | Q1 2026 | |
| 14 | Alyeska Investment Group, L.P. | $787K | 75K | ▲New +75K sh | Q1 2026 | |
| 15 | Bellevue Group AG | $525K | 50K | ▲New +50K sh | Q1 2026 | |
| 16 | Laurion Capital Management LP | $525K | 50K | ▲New +50K sh | Q1 2026 | |
| 17 | SECTORAL ASSET MANAGEMENT INC | $477K | 44K | ▲New +44K sh | Q1 2026 | |
| 18 | GOLDMAN SACHS GROUP INC | $375K | 36K | ▲New +36K sh | Q1 2026 | |
| 19 | CITADEL ADVISORS LLC | $367K | 35K | ▲New +35K sh | Q1 2026 | |
| 20 | D. E. Shaw & Co., Inc. | $161K | 15K | ▲New +15K sh | Q1 2026 | |
| 21 | TWO SIGMA INVESTMENTS, LP | $149K | 14K | ▲New +14K sh | Q1 2026 | |
| 22 | JANE STREET GROUP, LLC | $134K | 13K | ▲New +13K sh | Q1 2026 | |
| 23 | UBS Group AG | $68K | 6K | ▲New +6K sh | Q1 2026 | |
| 24 | MORGAN STANLEY | $32K | 3K | ▲New +3K sh | Q1 2026 | |
| 25 | GAMMA Investing LLC | $17K | 1K | ▲New +1K sh | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Company | Co-held by | Combined value |
|---|---|---|
| CENTESSA PHARMACEUTICALS-ADRCNTA | 10 funds | $514.6M |
| REVOLUTION MEDICINES INCRVMD | 9 funds | $579.3M |
| TANGO THERAPEUTICS INCTNGX | 9 funds | $465.9M |
| COGENT BIOSCIENCES INCCOGT | 9 funds | $355.9M |
| MEDLINE INC-CL AMDLN | 8 funds | $220.2M |
| DISC MEDICINE INCIRON | 8 funds | $194.3M |
| NVIDIA CORPNVDA | 7 funds | $4.9B |
| META PLATFORMS INC-CLASS AMETA | 7 funds | $1.6B |
| MICROSOFT CORPMSFT | 7 funds | $1.3B |
| ALPHABET INC-CL AGOOGL | 7 funds | $1.1B |
| ABIVAX SA-ADRABVX | 7 funds | $927.5M |
| EDGEWISE THERAPEUTICS INCEWTX | 7 funds | $443.9M |
Ranked by how many of AGMB's institutional holders also hold each name, a cross-fund conviction signal.
No open-market insider transactions on file yet. Grants, gifts, and exercises live on the full insider page.
No filings captured for this ticker in the live stream yet.
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/AGMB/capital-change-brief"
Use Arkolith's capital_change_brief for AGMB. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for AGMB. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.